Home » Topics » BioWorld Science

BioWorld Science
RSS

Delayed tumor progression found with atrasentan in prostate cancer

June 16, 2004

First quarter 2004 clinical development highlights announced by PDL

June 16, 2004

Biovail's NDA for novel dosage form of citalopram accepted for review

June 16, 2004

Hemispherx submits clinical trial protocol to FDA for Alferon N

June 16, 2004

Evotec and Neuronova enter drug discovery agreement in depression, anxiety

June 16, 2004

Vertex and Mitsubishi sign agreement for VX-950 in Japan and Far East

June 16, 2004

Second of two phase III trials for Viramidine under way

June 16, 2004

ARRY-142886 enters phase I trial for advanced cancer

June 16, 2004

A6 enters phase II trial to prevent clinical relapse in ovarian cancer patients

June 16, 2004

EDEMA1 study of DX-88 meets primary endpoint

June 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...